A new era of
precision medicine
Nucleic acid therapeutics have significant potential to address diseases that historically have been challenging to treat with small molecule drugs or biologics.
Our unique chemistry platform opens up a world of potential, overcoming some of the historical challenges of oligonucleotide approaches to address a broad range of serious diseases. This fully integrated approach spanning discovery, manufacturing, supply and patient support creates a transformational, long-term platform beyond any one program.
